预测发生心房动的左心室缩现象型:动脉样硬化多民族研究
Lili Wang1, Jiayi Yi1, Zeming Zhou1
1National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|February 24, 2024
概括
左心室缩 (LVH) 现型预测心房动 (AF) 的风险. 具有高生物标志物的恶性LVH构成AF风险最高,改善了预测模型.
科学领域:
- 心脏病学 心脏病学
- 心脏成像 - - 心脏成像
- 流行病学 流行病学
背景情况:
- 左心室缩 (LVH) 与心房动 (AF) 有关.
- 不同的LVH表型对事件AF的预测能力需要进一步调查.
- 了解这些关联对于风险分层和预防策略至关重要.
研究的目的:
- 评估LVH表型对于发生的AF的预测价值.
- 为了比较与孤立的LVH与恶性LVH相关的风险.
- 在现有的AF风险模型中评估LVH表型的增量预测值.
主要方法:
- 利用了多民族动脉样硬化研究 (MESA) 的数据.
- 使用心脏磁共振成像和心脏生物标志物来定义LVH.
- 雇员接收机操作特征 (ROC) 分析以评估预测性绩效.
主要成果:
- 包括4983名参与者;279人 (5.6%) 患有孤立的LVH,222人 (4.5%) 患有恶性LVH.
- 在长达8.5年的随访期间,观察到272例发生的AF病例.
- 恶性LVH (HR: 4.13) 和孤立的LVH (HR: 1.82) 与没有LVH相比显著增加了AF风险.
结论:
- 在LVH表型中,AF发病率风险在LVH表型中存在显著差异.
- 恶性LVH具有发生性AF的最高风险.
- 结合LVH表型可以提高AF风险模型的预测准确度,例如CHARGE-AF.
更多相关视频
相关概念视频
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


